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A highly sensitive colorimetric
metalloimmunoassay based on copper-mediated
etching of gold nanorods†
Fangbin Cheng,a Zhaopeng Chen,*b Zhiyang Zhangb and Lingxin Chenb,c
A highly sensitive colorimetric metalloimmunoassay with a detec-
tion limit of 0.15 ng ml−1 for human IgG based on copper-
mediated etching of gold nanorods was proposed. The assay is
more sensitive than traditional ELISA, electrochemical metallo-
immunoassay and HRP mimic nanomaterial tag-based immunoassay.
Ultrasensitive sensing of biomolecules and metal ions, such as
biomarkers, dopamine, cysteine, Cu2+, Hg2+, Cd2+, Pb2+, etc.
plays a very important role in diverse areas, including clinical
diagnosis, food control and environmental monitoring.1–7 For
this purpose, many analytical techniques have been developed,
including nonmaterial-based colorimetry and fluorometry,
paper-based fluorometry, electrochemistry, atomic spectro-
metry, immunoassay, etc. Among these, immunoassay was
proved to be an effective and ultimately successful method for
the quantification of target analytes.8–11 Due to its long
history, a much more mature operation process and plenty of
encouraging experimental results, enzyme-linked immuno-
sorbent assay (ELISA) remains the most popular clinical detec-
tion approach.12–15 However, ELISA still suffers from the
inherent shortcomings of antigen/antibody–protein conju-
gates, such as easy denaturation and digestion by proteases,
the cumbersome production process and time-critical storage
life.16–18 To overcome these shortcomings, much efforts have
been focused on discovering better labels to conjugate anti-
gens or antibodies.16,19–22 Due to their unique physical and
biochemical properties, metal nanomaterials have been proven
to be effective tags in indicating the reaction between antigens
and antibodies. Normally, metal nanomaterial tags are quanti-
fied by electrochemistry, chemiluminescence, etc.23–27
Although these quantitative measurements provide some advan-
tages, such as low sample volume, excellent sensitivity and rela-
tively inexpensive instrumentation, the promotion and
application of these technologies are constrained by their com-
plicated procedures and rigorous experimental details. Spectro-
photometric immunoassay remains in the dominant position
because most hospitals and disease surveillance organizations,
even in remote poor areas or countries, possess microplate
readers and spectrophotometers rather than electrochemical or
chemiluminescence instruments. So it is necessary to develop
effective methods that can sensitively read nanomaterial tags
using microplate readers or spectrophotometers. For this
purpose, many HRP mimic nanomaterial tags, such as gra-
phene, Au@Pt, Pt@SiO2 and platinum nanoparticles, have been
applied to immunoassays.16,28–36 These methods have also
obtained high sensitivity that are comparable to ELISA due to
the high catalytic activity of the HRP mimics.
Methods based on catalytic etching of gold nanoparticles
have been proven to be simple and sensitive for colorimetric
detection of many target analytes, including Pb2+, Cu2+, Co2+,
MoO4
2−, etc.37–40 In this work, we combine the conventional
metalloimmunoassay with copper-mediated etching of gold
nanoparticles proposed in our previous work to develop an
effective immunoassay using a microplate reader or a spectro-
photometer as readout. The experiment results show that this
immunoassay is more sensitive than the traditional ELISA and
HRP mimic nanomaterial tag-based immunoassay.31,34,41,42
Scheme 1 outlines the procedure of the colorimetric
metalloimmunoassay based on copper-mediated etching of
gold nanorods using human IgG as the model antigen. Goat
anti-human IgG was first adsorbed onto a polystyrene micro-
plate physically. After a conventional sandwich immunoreac-
tion, different amounts of CuS nanocrystals labelled goat anti-
human IgG proportional to the target analyte (human IgG) was
captured onto the microplate (TEM image shows that the
spherical CuS nanocrystals are about 7 nm and the X-ray dif-
fraction pattern indicates that the synthesized CuS nanocrys-
tals are of high quality. Fig. S1 and S2 in the ESI†). The cupric
ion (Cu2+) was then released by the addition of hydrobromic
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acid and was determined based on the catalytic etching of
gold nanorods.
Fig. 1A shows the changes of the LSPR absorption (A), and
color (inset) of gold nanorods induced by different concen-
trations of Cu2+ which comes from the captured CuS nanocrys-
tals in the sandwich immunoreaction. The longitudinal LSPR
absorption peaks were located at 668, 596 and 555 nm respect-
ively after the incubation of gold nanorods with different con-
centrations of human IgG-mediated Cu2+. The solution of gold
nanorods also changed from blue to purple and then to red
with the increase of the concentration of human IgG. The
peak-shift and color change are attributed to the anisotropic
corrosion of gold nanorods along the longitudinal direction
due to the less surface passivation and/or the higher reaction
activities at the tips (Fig. 1B and C).43 Obviously, the peak-shift
and color change can be applied to indicate the target analyte
concentration.
It should be noted here that our previous work had not
investigated the oxidation product of gold nanorods.40 Here we
used mass spectrometry to identify the oxidation product. As
shown in Fig. S3 in the ESI†, the appearance of a peak at m/z
925 indicated the formation of AuBr2
−–(CTA+)2 where CTA
+ is
the abbreviation of cetyltrimethylammonium. The formation
of AuBr2
−–(CTA+)2, an ionassociation compound, can be
explained by the soft and hard acid–base theory that a cation
with a large volume tends to associate with an anion with a
large volume.43 According to our previous work and the mass
spectrometry experimental results, we conclude that colori-
metric sensing of the captured CuS is based on the following
chemical equations.
CuSþ 2Hþ ! Cu2þ þH2S
Cu2þ þ Auþ 4CTAþ þ 4Br ! CuBr2–ðCTAþÞ2
þ AuBr2–ðCTAþÞ2
4CuBr2–ðCTAþÞ2 þ O2 þ 4Hþ ! Cu2þ þ 8Br þ 8CTAþ
þ 2H2O
Fig. 2 shows the LSPR absorption spectra and the colors of
gold nanorods corresponding to different concentrations of
human IgG. The longitudinal LSPR peak shifted to a short
wavelength gradually with the increase in human IgG concen-
tration in the range of 0.3–20 ng ml−1, accompanied by a color
change from blue to purple and then to red. The LSPR peak-
Scheme 1 The schematic illustration of the procedure of the colori-
metric metalloimmunoassay.
Fig. 1 LSPR absorption spectra (A) and the colors (inset) corresponding
to 0 (a), 5 (b) and 10 ng ml−1 (c) human IgG. B and C are the TEM images
of gold nanorods corresponding to 0 (B) and 10 ng ml−1 (C) human IgG.
Fig. 2 LSPR absorption spectra and the colors of gold nanorods
corresponding to different concentrations of human IgG (ng ml−1). The
inset is the longitudinal LSPR peak-shift vs. the concentration of human
IgG (ng ml−1).
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shift could easily be monitored by using a simple microplate
reader or a spectrophotometer. The detection limit was calcu-
lated to be 0.15 ng ml−1 according to the S/N = 3 rule which is
lower than that of the traditional ELISA, HRP mimic nano-
material tag-based immunoassay and electrochemical metallo-
immunoassay and is comparable to the fluorescence
immunoassay (Table 1). The digital photo (Fig. 2B) shows that
as low as 5.0 ng ml−1 human IgG can be detected by the naked
eye. The eye-readable color change also makes the metalloim-
munoassay more convenient in clinical diagnosis, avoiding the
use of complex equipment.
High tolerance to interferents and good specificity of the
immunoassay can ensure the selective identification of the
target analyte from the complex matrix. Fig. 3 shows the speci-
ficity and tolerance of the proposed immunoassay. The almost
no obvious peak shift for the respective determination of
1.0 mg ml−1 lactoglobulin, glucose, creatinine, glutamine,
ascorbic acid, cysteine, catechin, papain, trypsin, peptone and
glycine, and 1.0 μM Ca2+, Mg2+, Al3+, Zn2+, Fe3+, Pb2+, Cu2+,
Hg2+, Ag+, Mn2+, Co2+, Ni2+, Cd2+, NO3
−, SO4
2− and the mixture
of these chemicals indicated that the metalloimmunoassay
displayed good specificity. The almost the same change in the
LSPR of gold nanorods for the determination of 10 ng ml−1
IgG in the presence and absence of the mixture of the above
mentioned chemicals indicated that the proposed metallo-
immunoassay possessed high tolerance to those chemicals.
Commonly, immunoassays are used to quantify target ana-
lytes in serum. An immunoassay with good specificity means
the abundance of proteins, salts and other small molecules,
such as glucose, ascorbic acid, etc., will do not interfere with
the detection. Since the normal concentration of human IgG
in human serum reaches mg mL−1 levels, direct detection of
human IgG in diluted human serum cannot evaluate the speci-
ficity of the proposed immunoassay. In consideration of the
fact that the concentrations of proteins, salts and other small
molecules in animal serum are comparable to human serum,
here we choose the determination of spiked human IgG in
fetal bovine serum (FBS) to investigate the specificity. The
detection results are shown in Table 2. The recoveries of the
spiked human IgG ranged from 104.2% to 106.7%. The satis-
factory recoveries for determination of low concentrations of
human IgG indicate that such a method has good specificity
and is applicable to the quantification of low abundance pro-
teins in complex biological samples, avoiding the interference
from proteins, salts and other small molecules.
In conclusion, here we have developed a highly sensitive
colorimetric metalloimmunoassay based on copper-mediated
etching of gold nanorods. Since the cupric ion can accelerate
the etching of gold nanorods by dissolved oxygen dramatically,
the amount of captured CuS nanocrystals in a sandwich
Fig. 3 LSPR peak shift of gold nanorods corresponding to 1.0 mg ml−1
lactoglobulin, glucose, creatinine, glutamine, ascorbic acid, cysteine,
catechin, papain, trypsin, peptone and glycine, and 1.0 μM Ca2+, Mg2+,
Al3+, Zn2+, Fe3+, Pb2+, Cu2+, Hg2+, Ag+, Mn2+, Co2+, Ni2+, Cd2+, NO3
−,
SO4
2−, the mixture of these chemicals, 10 ng ml−1 human IgG.
Table 2 Determination results in the spiked sample by the proposed
metalloimmunoassay
Samples Added, ng ml−1 Found, ng ml−1 Recovery
FBS 0.7 0.73 ± 0.02 104.3 ± 2.8
3.0 3.2 ± 0.1 106.7 ± 3.3
7.0 7.3 ± 0.4 104.2 ± 5.7
Table 1 Comparison of immunoassay methods developed for IgG
Label Immunoassay format Analytical technique Detection limit, ng ml−1 Ref.
HRP ELISA Spectrophotometry 1.0 34
HPR Immunomagnetic beads/sandwich Spectrophotometry 2.4 42
Ap ELISA Spectrophotometry 1.0 41
Ap ELISA Luminescence 0.03 41
Au Microwells/sandwich Stripping voltammetry 0.5 23
CdS Immunomagnetic beads/sandwich Stripping voltammetry 10 24
Au Capillary electrophoresis/homogeneous Chemiluminescence 1.14 25
Au/HRP Immunomagnetic beads/sandwich Stripping voltammetry 0.26 42
Au/HRP Immunomagnetic beads/sandwich Spectrophotometry 0.05 42
Eu-BCPDA Microwells/sandwich Time-resolved fluorescence 0.1 41
Pt Microwells/sandwich Spectrophotometry 2.5 34
Si@Pt Microwells/sandwich Spectrophotometry 10 31
CuS Microwells/sandwich Spectrophotometry 0.15 This work
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immunoreaction process can be monitored by using a simple
microplate reader, spectrophotometer and even by the naked
eye for the assay of the target analyte with relatively high con-
centrations, making the metalloimmunoassay easier and more
convenient. The metalloimmunoassay is also more sensitive
than the traditional ELISA, electrochemical immunoassay and
HRP mimic nanomaterial tag-based immunoassay and com-
parable to the fluorescence immunoassay. The good specificity
confirmed by the determination of human IgG in spiked
samples indicates that the metalloimmunoassay is applicable
to the quantification of the target analyte in complex samples.
In the consideration of the pervasive application of immuno-
assays, the metalloimmunoassay promises to be an effective
approach in clinical diagnosis and environmental analysis for
detection of biomarkers and contaminants, such as heavy
metal ions, pesticides and pathogenic bacteria.
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